These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 27682892)

  • 1. Development of a Multi-Target Contingency Management Intervention for HIV Positive Substance Users.
    Stitzer M; Calsyn D; Matheson T; Sorensen J; Gooden L; Metsch L
    J Subst Abuse Treat; 2017 Jan; 72():66-71. PubMed ID: 27624618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influencing quality of outpatient SUD care: Implementation of alerts and incentives in Washington State.
    Garnick DW; Horgan CM; Acevedo A; Lee MT; Panas L; Ritter GA; Campbell K; Bean-Mortinson J
    J Subst Abuse Treat; 2017 Nov; 82():93-101. PubMed ID: 29021122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost and Activity Analysis of Patient Navigation for Persons With HIV: Comparing Health Department and Health Clinic Delivered Interventions.
    Lightner JS; Moore E; Barnhart T; Rajabiun S
    Health Promot Pract; 2024 Apr; ():15248399241245059. PubMed ID: 38605560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. US state laws relevant to incentives for health behavior: A qualitative analysis.
    Andraka-Christou B; Williams M; Buksbaum S; Karkkainen J; Stein BD; Batchelder SR; Peck K; Heil SH; Rawson R; Sigmon SC
    Prev Med; 2023 Nov; 176():107645. PubMed ID: 37494973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use.
    Traynor SM; Metsch LR; Gooden L; Stitzer M; Matheson T; Tross S; Carrico AW; Jain MK; Del Rio C; Feaster DJ
    Drug Alcohol Depend; 2021 Apr; 221():108567. PubMed ID: 33610093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification.
    Acevedo A; Lee MT; Garnick DW; Horgan CM; Ritter GA; Panas L; Campbell K; Bean-Mortinson J
    Drug Alcohol Depend; 2018 Feb; 183():192-200. PubMed ID: 29288914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.
    Rash CJ; Stitzer M; Weinstock J
    J Subst Abuse Treat; 2017 Jan; 72():10-18. PubMed ID: 27746057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is recovery planning any different from treatment planning?
    Borkman TJ
    J Subst Abuse Treat; 1998; 15(1):37-42. PubMed ID: 9534125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key ingredients to effective addictions treatment.
    Waltman D
    J Subst Abuse Treat; 1995; 12(6):429-39. PubMed ID: 8749727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of Client Incentives within a Recovery Navigation Program.
    Brolin M; Torres M; Hodgkin D; Horgan C; Lee M; Merrick E; Ritter G; Panas L; DeMarco N; Hopwood J; Gewirtz A; Straus J; Harrington J; Lane N
    J Subst Abuse Treat; 2017 Jan; 72():25-31. PubMed ID: 27682892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost Savings from a Navigator Intervention for Repeat Detoxification Clients.
    Hodgkin D; Brolin MF; Ritter GA; Torres ME; Merrick EL; Horgan CM; Hopwood JC; De Marco N; Gewirtz A
    J Ment Health Policy Econ; 2019 Mar; 22(1):3-13. PubMed ID: 30991351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the feasibility and impact of case rate payment for recovery support navigator services: a mixed methods study.
    Torres ME; Brolin M; Panas L; Ritter G; Hodgkin D; Lee M; Merrick E; Horgan C; Hopwood JC; Gewirtz A; De Marco N; Lane N
    BMC Health Serv Res; 2020 Nov; 20(1):1004. PubMed ID: 33143701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment.
    Mitchell SG; Monico LB; Stitzer M; Matheson T; Sorensen JL; Feaster DJ; Schwartz RP; Metsch L
    J Subst Abuse Treat; 2018 Nov; 94():18-23. PubMed ID: 30243412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of recovery support navigators on continuity of care after detoxification.
    Lee MT; Torres M; Brolin M; Merrick EL; Ritter GA; Panas L; Horgan CM; Lane N; Hopwood JC; De Marco N; Gewirtz A
    J Subst Abuse Treat; 2020 May; 112():10-16. PubMed ID: 32199540
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.